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Reply to the Editor:
We thank Dr Corno for his suggestion that
normothermic high-flow cardiopulmonary
bypass would be likely to improve neuro-
developmental outcome relative to circula-
tory arrest or hypothermic reduced flow
bypass, the two techniques that we studied.
We agree with Dr Corno that many perfu-
sion variables may influence late develop-
mental outcome, and we recognize that few
of these have been studied in detail. The
Boston Circulatory Arrest Study, the sub-
ject of our recent report, was designed in
1987. Since that time, our laboratory stud-
ies have led us to undertake two subsequent
prospective randomized clinical trials, one
studying the role of pH1 and one studying
the role of hematocrit in influencing out-
2come after cardiopulmonary bypass. Both
1858 The Journal of Thoracic and Cardiovtrials confirmed our laboratory results and
resulted in important changes in our tech-
nique of bypass. However, our more recent
laboratory studies investigating different
temperature strategies for cardiopulmonary
bypass have suggested that there is a dis-
advantage in using a higher temperature for
cardiopulmonary bypass. For example, in a
study that used intravital microscopy for
direct examination of the cerebral micro-
circulation, we observed greater activation
of white cells with increased numbers of
rolling and adherent white cells when car-
diopulmonary bypass was conducted at
34°C than at 15°C.3 We believe that this
result reflects the fact that, despite Dr Cor-
no’s assertion to the contrary, cardiopul-
monary bypass remains far from being a
physiologic state. It is widely known that
cardiopulmonary bypass is associated with
multiple systemic inflammatory effects,
both humoral and cellular. Our laboratory
study has confirmed that a higher temper-
ature exacerbates this inflammatory re-
sponse. In addition, the high flow rate that
is required to support the greater metabolic
rate associated with a higher temperature
also carries many disadvantages, including
increased generation of emboli, increased
left heart return necessitating greater suc-
tion volumes, reduced intracardiac expo-
sure because of the need for multiple can-
nulas and increased left heart return, less
effective myocardial protection with need
for multiple reinfusions of cardioplegia
(demonstrated to be a disadvantage in the
neonate), and a reduced margin for safety
in the event of equipment failure. The the-
ascular Surgery ● June 2004oretical disadvantages of increased infec-
tion and bleeding that might result from
hypothermia have not been confirmed in
the neonate and infant.
In conclusion, we hope that Dr Corno
and his associates will have the opportunity
in the future to undertake developmental
studies of their many patients who undergo
normothermic high-flow bypass. Our own
clinical studies will continue to be guided
by translational research undertaken in the
laboratory, which to date has not indicated
any advantage for normothermic high-flow
bypass.
Richard A. Jonas, MD
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